Co-Authors
This is a "connection" page, showing publications co-authored by Jake Dunning and Peter Horby.
Connection Strength
0.814
-
Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic. Clin Infect Dis. 2018 04 17; 66(9):1454-1457.
Score: 0.191
-
Insights from clinical research completed during the west Africa Ebola virus disease epidemic. Lancet Infect Dis. 2017 09; 17(9):e280-e292.
Score: 0.179
-
Clinical Trials of Therapeutics for the Prevention of Congenital Zika Virus Disease: Challenges and Potential Solutions. Ann Intern Med. 2017 May 16; 166(10):725-732.
Score: 0.177
-
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021 04; 9(4):349-359.
Score: 0.058
-
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 09 09; 370:m3339.
Score: 0.056
-
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020 08 27; 370:m3249.
Score: 0.056
-
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May 22; 369:m1985.
Score: 0.055
-
Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases. Virus Evol. 2016 Jan; 2(1):vew016.
Score: 0.042